Stockreport

Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property

NORTHWEST BIOTHRPUTCS INC  (NWBO) 
US:NASDAQ Investor Relations: nwbio.com/investors-media
PDF Complementary to Technology & IP Already Owned or In-Licensed;Significant Step in Building a Leading Dendritic Cell Franchise BETHESDA, Md., June 17, 2024 /PRNewswire/ - [Read more]